Raymond James Financial Services Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,754
Closed -$100K 3276
2022
Q1
$100K Sell
11,754
-7,018
-37% -$49.3K ﹤0.01% 3117
2021
Q4
$166K Sell
18,772
-1,319
-7% -$12.5K ﹤0.01% 3032
2021
Q3
$209K Buy
+20,091
New +$176K ﹤0.01% 2952

Other funds holding SRTA

Raymond James Financial Services Advisors's SRTA Position: Q2 2022 in Review

Raymond James Financial Services Advisors sold out of Strata Critical Medical Inc (SRTA) in Q2 2022, closing a stake of 11,754 shares — an estimated $100K sold.

Raymond James Financial Services Advisors first reported a position in SRTA in Q3 2021 and held it in 3 quarters. The position peaked at $209K in Q3 2021. 96 funds tracked by Wall St. Rank hold SRTA as of Q2 2022.

  • Raymond James Financial Services Advisors reported no remaining Strata Critical Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 11,754 Strata Critical Medical Inc shares in Q2 2022, an estimated $100K.
  • Raymond James Financial Services Advisors first reported a position in Strata Critical Medical Inc in Q3 2021 and held it in 3 quarters.
  • Raymond James Financial Services Advisors's Strata Critical Medical Inc position peaked at $209K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.